1小时集束化治疗对急诊疑似脓毒症患者死亡率的影响:阶梯楔形整群随机临床试验
该研究为在法国和西班牙23个急诊科开展的实用性阶梯楔形整群随机试验,纳入符合Sepsis-3标准或快速SOFA评分≥2或乳酸>2 mmol/L的成人疑似脓毒症患者。干预为实施1小时脓毒症集束化治疗(包括乳酸测量、血培养、广谱抗生素、低血压或乳酸≥4 mmol/L时30 mL/kg晶体液)。主要终点为住院死亡率(截尾至28天):干预组12.1% vs 对照组12.6%,差异-0.4%(95%CI -5.1至4.2),调整相对风险0.81(95%CI 0.48至1.39),无显著差异。抗生素给药中位时间干预组40分钟 vs 对照组113分钟(差异-73分钟,95%CI -93至-53),干预组3小时内液体复苏的比例、量更高且时间更短。作者认为研究可能把握度不足。
要点
- 在23个急诊科疑似脓毒症患者中,1小时集束化治疗未显著降低住院死亡率(12.1% vs 12.6%,aRR 0.81, 95%CI 0.48-1.39)。
- 1小时集束化治疗显著缩短抗生素给药时间:中位40分钟 vs 113分钟(差异-73分钟,95%CI -93至-53)。
- 干预组3小时内液体复苏的比例更高、量更大且时间更短;其他次要终点两组无差异。
- 作者认为该研究可能把握度不足,未能报告组间统计学显著差异。
适用人群与场景
- 法国和西班牙23个急诊科的成人患者,符合Sepsis-3标准或快速SOFA评分≥2或乳酸>2 mmol/L。
诊断标准与关键阈值
- 疑似脓毒症:符合Sepsis-3标准或快速SOFA评分≥2或乳酸>2 mmol/L。
- 1小时集束化治疗包括:乳酸测量、血培养、广谱抗生素给药、低血压或乳酸≥4 mmol/L时给予30 mL/kg晶体液。
处置流程与药物剂量
- 干预为实施1小时脓毒症集束化治疗:乳酸测量、血培养、广谱抗生素、低血压或乳酸≥4 mmol/L时30 mL/kg晶体液。
研究设计与关键结果
- 研究类型:实用性阶梯楔形整群随机试验,在法国和西班牙23个急诊科开展;计划分析1148例,研究期在纳入873例后结束;最终分析872例(平均年龄66岁,女性42%),干预组387例(44.4%),对照组485例(55.6%)。
- 基线中位SOFA评分3分[1-5]。
- 主要终点住院死亡率(截尾至28天):干预组47例(12.1%) vs 对照组61例(12.6%),百分比差异-0.4%(95%CI -5.1至4.2),调整相对风险0.81(95%CI 0.48至1.39)。
- 抗生素给药中位时间:干预组40分钟 vs 对照组113分钟(差异-73分钟,95%CI -93至-53)。
- 干预组3小时内液体复苏的比例更高、量更大且时间更短。
- 其他次要终点(24小时液体复苏量、24小时急性心力衰竭、72小时SOFA评分、ICU住院时长、机械通气或肾脏替代治疗天数、无血管加压药天数、不必要抗生素使用、28天死亡率)两组无差异。
证据类型、等级与局限
- 证据类型:实用性阶梯楔形整群随机临床试验。
- 局限:作者认为该研究可能把握度不足,未能报告组间统计学显著差异。
对床旁实践的改变
- 在急诊疑似脓毒症患者中,实施1小时集束化治疗未显著改变住院死亡率,但显著缩短抗生素给药时间并增加3小时内液体复苏。
- 作者认为该研究可能把握度不足,未能报告组间统计学显著差异。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: The efficacy of the 1-h bundle for emergency department (ED) patients with suspected sepsis, which includes lactate measurement, blood culture, broad-spectrum antibiotics administration, administration of 30 mL/kg crystalloid fluid for hypotension or lactate ≥ 4 mmol/L, remains controversial.
METHODS: We carried out a pragmatic stepped-wedge cluster-randomized trial in 23 EDs in France and Spain. Adult patients with Sepsis-3 criteria or a quick sequential organ failure assessment (SOFA) score ≥ 2 or a lactate > 2 mmol/L were eligible. The intervention was the implementation of the 1-h sepsis bundle. The primary outcome was in-hospital mortality truncated at 28 days. Secondary outcomes included volume of fluid resuscitation at 24 h, acute heart failure at 24 h, SOFA score at 72 h, intensive care unit (ICU) length of stay, number of days on mechanical ventilation or renal replacement therapy, vasopressor free days, unnecessary antibiotic administration, and mortality at 28 days. 1148 patients were planned to be analysed; the study period ended after 873 patients were included.
RESULTS: 872 patients (mean age 66, 42% female) were analyzed: 387 (44.4%) in the intervention group and 485 (55.6%) in the control group. Median SOFA score was 3 [1-5]. Median time to antibiotic administration was 40 min in the intervention group vs 113 min in the control group (difference - 73 [95% confidence interval (CI) - 93 to - 53]). There was a significantly higher rate, volume, and shorter time to fluid resuscitation within 3 h in the intervention group. There were 47 (12.1%) in-hospital deaths in the intervention group compared to 61 (12.6%) in the control group (difference in percentage - 0.4 [95% CI - 5.1 to 4.2], adjusted relative risk (aRR) 0.81 [95% CI 0.48 to 1.39]). There were no differences between groups for other secondary endpoints.
CONCLUSIONS: Among patients with suspected sepsis in the ED, the implementation of the 1-h sepsis bundle was not associated with significant difference in in-hospital mortality. However, this study may be underpowered to report a statistically significant difference between groups.
参考来源
- Freund Y, Cancella de Abreu M, Lebal S, et al. Effect of the 1-h bundle on mortality in patients with suspected sepsis in the emergency department: a stepped wedge cluster randomized clinical trial. Intensive Care Med. 2024. PMID: 38913098. doi:10.1007/s00134-024-07509-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。